FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical

White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.

White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.

blood plasma
Doctors Forge Ahead with Plasma for COVID-19, Benefits Uncertain
Doctors Forge Ahead with Plasma for COVID-19, Benefits Uncertain
Shawna Williams | Aug 14, 2020
Researchers say the popularity of convalescent plasma makes it more difficult to gather high-quality data on its efficacy.
Special Report
What Do Antibody Tests For SARS-CoV-2 Tell Us About Immunity?
What Do Antibody Tests For SARS-CoV-2 Tell Us About Immunity?
Katarina Zimmer | Apr 15, 2020
Studies from serum samples could transform our understanding of the spread of COVID-19, but what antibodies alone say about immunity is not yet clear.
Monkeys Develop Protective Antibodies to SARS-CoV-2
Monkeys Develop Protective Antibodies to SARS-CoV-2
Katarina Zimmer | Mar 17, 2020
A small study of macaques finds they don’t develop a coronavirus infection the second time they are exposed, supporting the idea of using plasma from recovered patients as a treatment for COVID-19.
The Latest Drug Trials for Coronavirus
The Latest Drug Trials for Coronavirus
Ashley Yeager | Feb 18, 2020
Under careful watch of the World Health Organization, doctors will test a range of COVID-19 therapies, including HIV and flu antivirals, blood plasma infusions, and traditional Chinese medicines.
Young Blood Unproven as Anti-Aging Treatment: US FDA
Young Blood Unproven as Anti-Aging Treatment: US FDA
Carolyn Wilke | Feb 20, 2019
The agency warns that plasma treatments costing thousands of dollars, which supposedly treat the infirmities of old age, have not been proven “safe or effective.”
Equivocal Findings of Alzheimer’s Trial Using Young Blood
Equivocal Findings of Alzheimer’s Trial Using Young Blood
Catherine Offord | Nov 5, 2017
A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.